We have a new price target for GILD.
Let's take a look at the charts and indicators.
These companies have the potential to help in battling the Covid-19 pandemic.
The drugmaker that is partnering with Sanofi to develop a vaccine has seen its shares push higher after declining to a low in late March.
There is no joy in stockville -- instead we have big companies with stocks rising. Here's why that is and what you need to understand about the rally amid the crisis.
Let's review the charts and indicators.
An inspiring performance.
Long-time investors in JNJ are probably not surprised how well the stock has responded in the past few weeks.
There are plenty of good reasons to invest in JNJ, but one resonates with me more than any other.
ABT is trading lower so far this Monday, and a pull back this week could allow traders a chance to buy weakness.